These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26504783)

  • 1. Potential of Newborn and Adult Stem Cells for the Production of Vascular Constructs Using the Living Tissue Sheet Approach.
    Bourget JM; Gauvin R; Duchesneau D; Remy M; Auger FA; Germain L
    Biomed Res Int; 2015; 2015():168294. PubMed ID: 26504783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells: roles and relationships in vascularization.
    Melchiorri AJ; Nguyen BN; Fisher JP
    Tissue Eng Part B Rev; 2014 Jun; 20(3):218-28. PubMed ID: 24410463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells.
    Krawiec JT; Weinbaum JS; St Croix CM; Phillippi JA; Watkins SC; Rubin JP; Vorp DA
    Tissue Eng Part A; 2015 Feb; 21(3-4):426-37. PubMed ID: 25119584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy to engineer small-diameter vascular grafts from marrow-derived mesenchymal stem cells.
    Zhao J; Liu L; Wei J; Ma D; Geng W; Yan X; Zhu J; Du H; Liu Y; Li L; Chen F
    Artif Organs; 2012 Jan; 36(1):93-101. PubMed ID: 21790675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living-engineered valves for transcatheter venous valve repair.
    Weber B; Robert J; Ksiazek A; Wyss Y; Frese L; Slamecka J; Kehl D; Modregger P; Peter S; Stampanoni M; Proulx S; Falk V; Hoerstrup SP
    Tissue Eng Part C Methods; 2014 Jun; 20(6):451-63. PubMed ID: 24156382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineering vascularized tissue constructs using an injectable cell-laden enzymatically crosslinked collagen hydrogel derived from dermal extracellular matrix.
    Kuo KC; Lin RZ; Tien HW; Wu PY; Li YC; Melero-Martin JM; Chen YC
    Acta Biomater; 2015 Nov; 27():151-166. PubMed ID: 26348142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel single-step self-assembly approach for the fabrication of tissue-engineered vascular constructs.
    Gauvin R; Ahsan T; Larouche D; Lévesque P; Dubé J; Auger FA; Nerem RM; Germain L
    Tissue Eng Part A; 2010 May; 16(5):1737-47. PubMed ID: 20038201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells.
    Zhao Y; Zhang S; Zhou J; Wang J; Zhen M; Liu Y; Chen J; Qi Z
    Biomaterials; 2010 Jan; 31(2):296-307. PubMed ID: 19819544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving PEEK bioactivity for craniofacial reconstruction using a 3D printed scaffold embedded with mesenchymal stem cells.
    Roskies M; Jordan JO; Fang D; Abdallah MN; Hier MP; Mlynarek A; Tamimi F; Tran SD
    J Biomater Appl; 2016 Jul; 31(1):132-9. PubMed ID: 26980549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.
    Cantore S; Crincoli V; Boccaccio A; Uva AE; Fiorentino M; Monno G; Bollero P; Derla C; Fabiano F; Ballini A; Santacroce L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):466-469. PubMed ID: 29692270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).
    Gong Z; Niklason LE
    FASEB J; 2008 Jun; 22(6):1635-48. PubMed ID: 18199698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Different Cell Types and Sources on Pre-Vascularisation in Fibrin and Agarose-Collagen Gels.
    Kniebs C; Kreimendahl F; Köpf M; Fischer H; Jockenhoevel S; Thiebes AL
    Organogenesis; 2020; 16(1):14-26. PubMed ID: 31809643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatin-based 3D conduits for transdifferentiation of mesenchymal stem cells into Schwann cell-like phenotypes.
    Uz M; Büyüköz M; Sharma AD; Sakaguchi DS; Altinkaya SA; Mallapragada SK
    Acta Biomater; 2017 Apr; 53():293-306. PubMed ID: 28213098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical properties of tissue-engineered vascular constructs produced using arterial or venous cells.
    Gauvin R; Guillemette M; Galbraith T; Bourget JM; Larouche D; Marcoux H; Aubé D; Hayward C; Auger FA; Germain L
    Tissue Eng Part A; 2011 Aug; 17(15-16):2049-59. PubMed ID: 21457095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell sheets: a new cell-based strategy for bone repair and regeneration.
    Chen M; Xu Y; Zhang T; Ma Y; Liu J; Yuan B; Chen X; Zhou P; Zhao X; Pang F; Liang W
    Biotechnol Lett; 2019 Mar; 41(3):305-318. PubMed ID: 30680496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells.
    Generali M; Casanova EA; Kehl D; Wanner D; Hoerstrup SP; Cinelli P; Weber B
    Acta Biomater; 2019 Oct; 97():333-343. PubMed ID: 31344511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biomimetic three-layered compartmented scaffold for vascular tissue engineering.
    Rainer A; Centola M; Spadaccio C; De Porcellinis S; Abbruzzese F; Genovese JA; Trombetta M
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():839-42. PubMed ID: 21096314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrices as advanced scaffolds for vascular tissue engineering.
    Piterina AV; Callanan A; Davis L; Meaney C; Walsh M; McGloughlin TM
    Biomed Mater Eng; 2009; 19(4-5):333-48. PubMed ID: 20042800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.